摘要
目的观察我院用磷酸奥司他韦治疗甲型H1N1流行性感冒的临床疗效和不良反应。方法对临床确诊的40例甲型H1N1流行性感冒患者均用磷酸奥司他韦进行治疗。结果除2例患者要求中途停止治疗外,38例患者均治愈出院,其中出现不良反应有3例,不良反应发生率为7.89%。结论磷酸奥司他韦对甲型H1N1流行性感冒有效,不良反应发生率相对较高。
Objective To observe clinical efficacy and adverse drug reactions（ADR）of Oseltamivir Phosphate in treatment of influenza A（H1N1） diseases in our hospital.Methods Forty cases of the influenza A（H1N1） diseases were treated with Oseltamivir Phosphate.Results Two cases the influenza A（H1N1） diseases stopped curing midway.Thirty--eigth cases of the influenza A（H1N1） diseases were cured,three cases have adverse reaction. The incident rate of adverse reaction was 7.89%.Conclusion Oseltamivir Phosphate was effictive in treatment of influenza A（HIN1）diseases,but the incident rate of adverse reaction was higher relatively.
出处
《中国卫生产业》
2011年第10X期39-40,共2页
China Health Industry
